The landscape of dementia diagnosis has evolved substantially with the arrival of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that may detect Alzheimer's pathology many years before indications arise. Although these technological advances stand for amazing progress in understanding neurodegenerative disorders, they have not diminished https://dukex087doz9.evawiki.com/user